0001567619-21-022503.txt : 20211223 0001567619-21-022503.hdr.sgml : 20211223 20211223162601 ACCESSION NUMBER: 0001567619-21-022503 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211221 FILED AS OF DATE: 20211223 DATE AS OF CHANGE: 20211223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRUTCHFIELD BRADFORD CENTRAL INDEX KEY: 0001246406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39035 FILM NUMBER: 211517465 MAIL ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94547 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 10x Genomics, Inc. CENTRAL INDEX KEY: 0001770787 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 455614458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 401-7300 MAIL ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: 10X Genomics, Inc. DATE OF NAME CHANGE: 20190315 4 1 doc1.xml FORM 4 X0306 4 2021-12-21 0 0001770787 10x Genomics, Inc. TXG 0001246406 CRUTCHFIELD BRADFORD C/O 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 0 1 0 0 Chief Commercial Officer Class A Common Stock 2021-12-21 4 M 0 4688 1.20 A 47743 D Class A Common Stock 2021-12-21 4 M 0 49910 5.04 A 97653 D Stock Option (right to buy) 1.2 2021-12-21 4 M 0 4688 0 D 2027-10-18 Class A Common Stock 4688 0 D Stock Option (right to buy) 5.04 2021-12-21 4 M 0 49910 0.00 D 2028-11-02 Class A Common Stock 49910 61757 D This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. /s/ Eric S. Whitaker, as Attorney-in-Fact 2021-12-23